Skip to main content

Sodium Bicarbonate Use During Pediatric Cardiopulmonary Resuscitation: A Secondary Analysis of the ICU-RESUScitation Project Trial.

Publication ,  Journal Article
Cashen, K; Reeder, RW; Ahmed, T; Bell, MJ; Berg, RA; Burns, C; Carcillo, JA; Carpenter, TC; Dean, JM; Diddle, JW; Federman, M; Fink, EL ...
Published in: Pediatr Crit Care Med
October 1, 2022

OBJECTIVES: To evaluate associations between sodium bicarbonate use and outcomes during pediatric in-hospital cardiac arrest (p-IHCA). DESIGN: Prespecified secondary analysis of a prospective, multicenter cluster randomized interventional trial. SETTING: Eighteen participating ICUs of the ICU-RESUScitation Project (NCT02837497). PATIENTS: Children less than or equal to 18 years old and greater than or equal to 37 weeks post conceptual age who received chest compressions of any duration from October 2016 to March 2021. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Child and event characteristics, prearrest laboratory values (2-6 hr prior to p-IHCA), pre- and intraarrest hemodynamics, and outcomes were collected. In a propensity score weighted cohort, the relationships between sodium bicarbonate use and outcomes were assessed. The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation (ROSC) and survival to hospital discharge with favorable neurologic outcome. Of 1,100 index cardiopulmonary resuscitation events, median age was 0.63 years (interquartile range, 0.19-3.81 yr); 528 (48.0%) received sodium bicarbonate; 773 (70.3%) achieved ROSC; 642 (58.4%) survived to hospital discharge; and 596 (54.2%) survived to hospital discharge with favorable neurologic outcome. Among the weighted cohort, sodium bicarbonate use was associated with lower survival to hospital discharge rate (adjusted odds ratio [aOR], 0.7; 95% CI, 0.54-0.92; p = 0.01) and lower survival to hospital discharge with favorable neurologic outcome rate (aOR, 0.69; 95% CI, 0.53-0.91; p = 0.007). Sodium bicarbonate use was not associated with ROSC (aOR, 0.91; 95% CI, 0.62-1.34; p = 0.621). CONCLUSIONS: In this propensity weighted multicenter cohort study of p-IHCA, sodium bicarbonate use was common and associated with lower rates of survival to hospital discharge.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Crit Care Med

DOI

ISSN

1529-7535

Publication Date

October 1, 2022

Volume

23

Issue

10

Start / End Page

784 / 792

Location

United States

Related Subject Headings

  • Sodium Bicarbonate
  • Prospective Studies
  • Pediatrics
  • Intensive Care Units
  • Infant
  • Humans
  • Heart Arrest
  • Cohort Studies
  • Child
  • Cardiopulmonary Resuscitation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cashen, K., Reeder, R. W., Ahmed, T., Bell, M. J., Berg, R. A., Burns, C., … for the                                  Eunice Kennedy Shriver                                  National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) and National Heart Lung and Blood Institute ICU-RESUScitation Project Investigators, . (2022). Sodium Bicarbonate Use During Pediatric Cardiopulmonary Resuscitation: A Secondary Analysis of the ICU-RESUScitation Project Trial. Pediatr Crit Care Med, 23(10), 784–792. https://doi.org/10.1097/PCC.0000000000003045
Cashen, Katherine, Ron W. Reeder, Tageldin Ahmed, Michael J. Bell, Robert A. Berg, Candice Burns, Joseph A. Carcillo, et al. “Sodium Bicarbonate Use During Pediatric Cardiopulmonary Resuscitation: A Secondary Analysis of the ICU-RESUScitation Project Trial.Pediatr Crit Care Med 23, no. 10 (October 1, 2022): 784–92. https://doi.org/10.1097/PCC.0000000000003045.
Cashen K, Reeder RW, Ahmed T, Bell MJ, Berg RA, Burns C, et al. Sodium Bicarbonate Use During Pediatric Cardiopulmonary Resuscitation: A Secondary Analysis of the ICU-RESUScitation Project Trial. Pediatr Crit Care Med. 2022 Oct 1;23(10):784–92.
Cashen, Katherine, et al. “Sodium Bicarbonate Use During Pediatric Cardiopulmonary Resuscitation: A Secondary Analysis of the ICU-RESUScitation Project Trial.Pediatr Crit Care Med, vol. 23, no. 10, Oct. 2022, pp. 784–92. Pubmed, doi:10.1097/PCC.0000000000003045.
Cashen K, Reeder RW, Ahmed T, Bell MJ, Berg RA, Burns C, Carcillo JA, Carpenter TC, Dean JM, Diddle JW, Federman M, Fink EL, Frazier AH, Friess SH, Graham K, Hall M, Hehir DA, Horvat CM, Huard LL, Maa T, Manga A, McQuillen PS, Morgan RW, Mourani PM, Nadkarni VM, Naim MY, Notterman D, Palmer CA, Pollack MM, Schneiter C, Sharron MP, Srivastava N, Wessel D, Wolfe HA, Yates AR, Zuppa AF, Sutton RM, Meert KL, for the                                  Eunice Kennedy Shriver                                  National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) and National Heart Lung and Blood Institute ICU-RESUScitation Project Investigators. Sodium Bicarbonate Use During Pediatric Cardiopulmonary Resuscitation: A Secondary Analysis of the ICU-RESUScitation Project Trial. Pediatr Crit Care Med. 2022 Oct 1;23(10):784–792.

Published In

Pediatr Crit Care Med

DOI

ISSN

1529-7535

Publication Date

October 1, 2022

Volume

23

Issue

10

Start / End Page

784 / 792

Location

United States

Related Subject Headings

  • Sodium Bicarbonate
  • Prospective Studies
  • Pediatrics
  • Intensive Care Units
  • Infant
  • Humans
  • Heart Arrest
  • Cohort Studies
  • Child
  • Cardiopulmonary Resuscitation